Long-term outcome and prognostic value of Ki67 after perioperative endocrine therapy in postmenopausal women with hormone-sensitive early breast cancer (POETIC): an open-label, multicentre, parallel-group, randomised, phase 3 trial

Smith et al. (Sun,) studied this question.

www.synapsesocial.com/papers/69d72916523bf2ea07f5097f — DOI: https://doi.org/10.1016/s1470-2045(20)30458-7

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. An updated PREDICT breast cancer prognostication and treatment benefit prediction model with independent validation· 2017 · 262 citations
2. Computer Program to Assist in Making Decisions About Adjuvant Therapy for Women With Early Breast Cancer· 2001 · 1,009 citations
3. Analytical validation of a standardized scoring protocol for Ki67: phase 3 of an international multicenter collaboration· 2016 · 152 citations
4. Regression modelling strategies for improved prognostic prediction· 1984 · 1,827 citations
5. Age as a prognostic factor in breast cancer· 1986 · 209 citations